This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Hold Centene (CNC) in Your Portfolio
by Zacks Equity Research
Robust revenue growth outlook, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.
Unlock the Value of Your Portfolio With 4 Low P/CF Stocks
by Sumit Singh
Value investing is essentially about selecting stocks that are cheap but fundamentally sound. Select Medical Holdings (SEM), Marathon Oil (MRO), PVH Corp. (PVH) and KB Home (KBH) boast low P/CF ratios.
UnitedHealth Group (UNH) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 3.63% and 1.02%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Best Growth Stocks to Buy for October 13th
by Zacks Equity Research
PANW, SEM and LW made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 13, 2023.
Best Income Stocks to Buy October 13th
by Zacks Equity Research
FANG, SEM and KUBTY made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 13, 2023.
Cigna's (CI) Evernorth Acquires Bright.md Technology Platform
by Zacks Equity Research
Cigna's (CI) Evernorth arm acquires Bright.md, enhancing MDLIVE's virtual care capabilities.
Cigna's (CI) Evernorth Launches Value-Based Care Program
by Zacks Equity Research
Cigna's (CI) Evernorth arm introduces a measurement-based care program for its behavioral health network.
Brookdale's (BKD) September 2023 Occupancy Volumes Increase
by Zacks Equity Research
Brookdale (BKD) has seen a continuous streak of 23 months of year-over-year increases in the weighted average occupancy level.
Best Growth Stocks to Buy for October 10th
by Zacks Equity Research
SEM, JELD and URBN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 10, 2023.
Ensign (ENSG) Buys Providence Place Nursing Facility in Kansas
by Zacks Equity Research
The Providence Place deal increases Ensign's (ENSG) portfolio to encompass 296 healthcare operations, spanning 13 states.
UnitedHealth (UNH) Arm Optum Partners With ProHealth Care
by Zacks Equity Research
Per the deal, more than 800 employees of ProHealth Care are likely to shift to UnitedHealth's (UNH) Optum business.
Elevance Health (ELV) to Expand in 91 New Counties in 2024
by Zacks Equity Research
Elevance Health (ELV) is set to enhance its product suite and expand to 91 counties in 2024, improving the overall health of people.
Should Value Investors Buy Molina Healthcare (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Hold Strategy is Apt for Teladoc (TDOC) Stock Now
by Zacks Equity Research
Teladoc's (TDOC) BetterHelp business is expected to gain from new member growth and stable customer acquisition costs.
Pick These 4 Low P/CF Stocks to Uplift Your Portfolio
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Select Medical (SEM), EnerSys (ENS), Marathon Oil (MRO) and Adtalem Global (ATGE) boast a low P/CF ratio.
Zacks.com featured highlights include Select Medical, Pampa Energia, Compania Cervecerias Unidas, Paysafe and EnerSys
by Zacks Equity Research
Select Medical, Pampa Energia, Compania Cervecerias Unidas, Paysafe and EnerSys are part of the Zacks Screen of the Week article.
5 Low Price-to-Book Stocks Suitable for Value Investors
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), Pampa Energia (PAM), Compania Cervecerias Unidas (CCU), Paysafe Limited (PSFE) and EnerSys (ENS) are some such stocks.
The Joint (JYNT) Forays Into West Virginia Chiropractic Market
by Zacks Equity Research
The Joint's (JYNT) new facility is positioned near the West Virginia University campus, at a high-traffic shopping center.
Elevance Health (ELV) Hits Pause on $2.5B BCBSLA Acquisition
by Zacks Equity Research
Elevance Health (ELV) and BCBS Louisiana have opted to withdraw the acquisition application from the Louisiana Department of Insurance.
Why Investors Are Retaining Pediatrix Medical (MD) Stock Now
by Zacks Equity Research
Pediatrix Medical's (MD) rising net patient service revenues will likely benefit its top line.
Here's Why Investors Should Retain Cigna (CI) Stock for Now
by Zacks Equity Research
Cigna's (CI) strong Evernorth and Cigna Healthcare segments, growing medical membership and a positive 2023 outlook poise it well for growth.
Here's Why Investors are Buying HCA Healthcare (HCA) Stock Now
by Zacks Equity Research
With seniors resuming delayed elective procedures, demand for services provided by HCA Healthcare (HCA) is likely to rise.
The Joint (JYNT) Q2 Earnings Miss Estimates, 2023 View Down
by Zacks Equity Research
The Joint (JYNT) expects to open 100-120 franchised clinics in 2023 compared with 121 opened last year.
Are Investors Undervaluing Select Medical (SEM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Low Price-to-Book Stocks to Buy in September
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), Office Properties Income Trust (OPI), KB Financial Group (KB), PagSeguro Digital Ltd. (PAGS) and EnerSys (ENS) are some such stocks.